293 related articles for article (PubMed ID: 26248894)
61. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
[TBL] [Abstract][Full Text] [Related]
62. Bone marrow microvessel density (MVD) in adult acute myeloid leukemia (AML): therapy induced changes and effects on survival.
Kuzu I; Beksac M; Arat M; Celebi H; Elhan AH; Erekul S
Leuk Lymphoma; 2004 Jun; 45(6):1185-90. PubMed ID: 15359999
[TBL] [Abstract][Full Text] [Related]
63. N-CAM (CD56) expression by CD34+ malignant myeloblasts has implications for minimal residual disease detection in acute myeloid leukemia.
Coustan-Smith E; Behm FG; Hurwitz CA; Rivera GK; Campana D
Leukemia; 1993 Jun; 7(6):853-8. PubMed ID: 7684798
[TBL] [Abstract][Full Text] [Related]
64. Prognostic significance of Ki67-negative blast cell clone in the high risk group of children treated for acute myeloid leukaemia.
Nowicki M; Ostalska-Nowicka D; Miśkowiak B
Folia Histochem Cytobiol; 2006; 44(1):49-52. PubMed ID: 16584092
[TBL] [Abstract][Full Text] [Related]
65. Relation of some cytochemical activities to the expression of CD34 marker in acute leukemia.
Klobusická M; Babusíková O; Hrivnáková A
Neoplasma; 1993; 40(5):309-14. PubMed ID: 7505888
[TBL] [Abstract][Full Text] [Related]
66. Bone marrow aspirate on the 14th day of induction treatment as a prognostic tool in de novo adult acute myeloid leukemia.
Liso V; Albano F; Pastore D; Carluccio P; Mele G; Lamacchia M; Mestice A; Specchia G
Haematologica; 2000 Dec; 85(12):1285-90. PubMed ID: 11114136
[TBL] [Abstract][Full Text] [Related]
67. Correlation between CD34 expression and chromosomal abnormalities but not clinical outcome in acute myeloid leukemia.
Fruchart C; Lenormand B; Bastard C; Boulet D; Lesesve JF; Callat MP; Stamatoullas A; Monconduit M; Tilly H
Am J Hematol; 1996 Nov; 53(3):175-80. PubMed ID: 8895688
[TBL] [Abstract][Full Text] [Related]
68. A segmentation method based on HMRF for the aided diagnosis of acute myeloid leukemia.
Su J; Liu S; Song J
Comput Methods Programs Biomed; 2017 Dec; 152():115-123. PubMed ID: 29054251
[TBL] [Abstract][Full Text] [Related]
69. Early clearance of peripheral blood blasts predicts response to induction chemotherapy in acute myeloid leukemia.
Arellano M; Pakkala S; Langston A; Tighiouart M; Pan L; Chen Z; Heffner LT; Lonial S; Winton E; Khoury HJ
Cancer; 2012 Nov; 118(21):5278-82. PubMed ID: 22517268
[TBL] [Abstract][Full Text] [Related]
70. Correlation between flow cytometric identification of CD33-positive cells and morphological evaluation of myeloblasts in bone marrow of patients with acute myeloblastic leukemia.
Oka S; Muroi K; Matsuyama T; Sato K; Ueda M; Toshima M; Suzuki T; Ozaki K; Mori M; Takubo T; Nagai T; Hanafusa T; Ozawa K
Hematology; 2009 Jun; 14(3):133-8. PubMed ID: 19490757
[TBL] [Abstract][Full Text] [Related]
71. Chronic myelomonocytic leukemia: The role of bone marrow biopsy immunohistology.
Orazi A; Chiu R; O'Malley DP; Czader M; Allen SL; An C; Vance GH
Mod Pathol; 2006 Dec; 19(12):1536-45. PubMed ID: 17041567
[TBL] [Abstract][Full Text] [Related]
72. Percentage of CD34 cells in a minimum 500-cell count in bone marrow trephines of patients with chronic myeloid leukaemia provides the best correlation with aspirate blast count.
Elliot V; Marin D; Horncastle D; Elderfield K; Apperley JF; Lampert IA; Naresh K
Br J Haematol; 2005 Aug; 130(3):460-1. PubMed ID: 16042700
[No Abstract] [Full Text] [Related]
73. Clinical significance of blast percentage assessed by bone marrow trephine biopsy and aspirate smear of myeloid malignancies.
Yang CF; Gau JP; Hsiao LT; Hsu CY
Pathology; 2021 Oct; 53(6):740-745. PubMed ID: 33745704
[TBL] [Abstract][Full Text] [Related]
74. Clinical impact of leukemic blast heterogeneity at diagnosis in cytogenetic intermediate-risk acute myeloid leukemia.
Hoffmann MH; Klausen TW; Boegsted M; Larsen SF; Schmitz A; Leinoe EB; Schmiegelow K; Hasle H; Bergmann OJ; Sorensen S; Nyegaard M; Dybkaer K; Johnsen HE
Cytometry B Clin Cytom; 2012 May; 82(3):123-31. PubMed ID: 22328535
[TBL] [Abstract][Full Text] [Related]
75. Human myeloid inhibitory C-lectin: a highly specific and stable acute myeloid leukemia marker.
Eissa DS; Kandeel EZ; Ghareeb M
Hematol Oncol; 2017 Dec; 35(4):814-820. PubMed ID: 27734526
[TBL] [Abstract][Full Text] [Related]
76. Cytoplasmic expression of nucleophosmin 1 as a marker for diagnosing residual disease of acute myeloid leukemia.
Dai Q; Ren Y
Appl Immunohistochem Mol Morphol; 2013 May; 21(3):205-11. PubMed ID: 23591014
[TBL] [Abstract][Full Text] [Related]
77. Comparison of the cellularity and presence of residual leukemia in bone marrow aspirate and biopsy specimens in pediatric patients with acute lymphoblastic leukemia (ALL) at day 7-14 of chemotherapy.
Kidd PG; Saminathan T; Drachtman RA; Ettinger LJ
Med Pediatr Oncol; 1997 Dec; 29(6):541-3. PubMed ID: 9324341
[TBL] [Abstract][Full Text] [Related]
78. Observation Versus Immediate Reinduction for Acute Myeloid Leukemia Patients With Indeterminate Day 14 Bone Marrow Results.
Jamy O; Bodine C; Sampat D; Sarmad R; Chadha A; Vachhani P; Papadantonakis N; Di Stasi A
Clin Lymphoma Myeloma Leuk; 2020 Jan; 20(1):31-38. PubMed ID: 31757719
[TBL] [Abstract][Full Text] [Related]
79. Low frequency of activity of P-glycoprotein (P-170) in acute lymphoblastic leukemia compared to acute myeloid leukemia.
Ludescher C; Eisterer W; Hilbe W; Gotwald M; Hofmann J; Zabernigg A; Cianfriglia M; Thaler J
Leukemia; 1995 Feb; 9(2):350-6. PubMed ID: 7869774
[TBL] [Abstract][Full Text] [Related]
80. [Minimal residual disease in acute myeloid leukemia in children--standardization and evaluation of immunophenotyping in the AML-BFM-98 study].
Reinhardt D; Langebrake C; Creutzig U; Vormoor J; Brune C; Thorwesten M; Ingiliz P; Hrusak O; Dworzak M; Griesinger F
Klin Padiatr; 2002; 214(4):179-87. PubMed ID: 12165899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
